Filing Details

Accession Number:
0001209191-22-015590
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-03 17:01:08
Reporting Period:
2022-03-01
Accepted Time:
2022-03-03 17:01:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1674930 Fulgent Genetics Inc. FLGT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1183863 C John Bolger C/O Fulgent Genetics, Inc.
4978 Santa Anita Ave.
Temple City CA 91780
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-01 625 $3.93 2,625 No 4 M Direct
Common Stock Disposition 2022-03-01 625 $61.42 2,000 No 4 S Direct
Common Stock Acquisiton 2022-03-01 625 $5.81 2,625 No 4 M Direct
Common Stock Disposition 2022-03-01 625 $61.40 2,000 No 4 S Direct
Common Stock Acquisiton 2022-03-01 625 $15.82 2,625 No 4 M Direct
Common Stock Disposition 2022-03-01 625 $61.27 2,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-03-01 625 $0.00 625 $3.93
Common Stock Stock Option (Right to Buy) Disposition 2022-03-01 625 $0.00 625 $5.81
Common Stock Stock Option (Right to Buy) Disposition 2022-03-01 625 $0.00 625 $15.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
313 2028-05-18 No 4 M Direct
1,563 2029-05-30 No 4 M Direct
2,813 2030-05-26 No 4 M Direct
Footnotes
  1. The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  2. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
  3. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
  4. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.